Dengue virus and West Nile virus protease inhibitors

Dengue virus and West Nile virus are important mosquito-borne pathogens of Flaviviridae family affecting millions of people worldwide and causing a severe global healthcare threat. However, currently there are no approved effective antiviral drugs or vaccines available for the treatment of virus inf...

Full description

Bibliographic Details
Main Author: Aravapalli, Sridhar
Other Authors: Groutas, William C.
Format: Others
Language:en_US
Published: Wichita State University 2013
Subjects:
Online Access:http://hdl.handle.net/10057/6719
id ndltd-WICHITA-oai-soar.wichita.edu-10057-6719
record_format oai_dc
spelling ndltd-WICHITA-oai-soar.wichita.edu-10057-67192013-11-15T04:59:45ZDengue virus and West Nile virus protease inhibitorsAravapalli, SridharElectronic dissertationsDengue virus and West Nile virus are important mosquito-borne pathogens of Flaviviridae family affecting millions of people worldwide and causing a severe global healthcare threat. However, currently there are no approved effective antiviral drugs or vaccines available for the treatment of virus infection. This thesis describes the design, synthesis and discovery of two novel classes of reversible competitive inhibitors of Dengue Virus and West Nile Virus NS2B/NS3 protease. Structure-activity relationship studies have led to the identification of a low micromolar hit, which will be used in a hit-to-lead campaign to generate lead compounds that display superior ADMET and PK characteristics.Thesis (Ph.D.)--Wichita State University, Fairmount College of Liberal Arts and Sciences, Dept. of ChemistryWichita State UniversityGroutas, William C.2013-11-14T19:10:49Z2013-11-14T19:10:49Z2013-05Dissertationxv, 100 p.d13002http://hdl.handle.net/10057/6719en_USCopyright Sridhar Aravapalli, 2013.
collection NDLTD
language en_US
format Others
sources NDLTD
topic Electronic dissertations
spellingShingle Electronic dissertations
Aravapalli, Sridhar
Dengue virus and West Nile virus protease inhibitors
description Dengue virus and West Nile virus are important mosquito-borne pathogens of Flaviviridae family affecting millions of people worldwide and causing a severe global healthcare threat. However, currently there are no approved effective antiviral drugs or vaccines available for the treatment of virus infection. This thesis describes the design, synthesis and discovery of two novel classes of reversible competitive inhibitors of Dengue Virus and West Nile Virus NS2B/NS3 protease. Structure-activity relationship studies have led to the identification of a low micromolar hit, which will be used in a hit-to-lead campaign to generate lead compounds that display superior ADMET and PK characteristics. === Thesis (Ph.D.)--Wichita State University, Fairmount College of Liberal Arts and Sciences, Dept. of Chemistry
author2 Groutas, William C.
author_facet Groutas, William C.
Aravapalli, Sridhar
author Aravapalli, Sridhar
author_sort Aravapalli, Sridhar
title Dengue virus and West Nile virus protease inhibitors
title_short Dengue virus and West Nile virus protease inhibitors
title_full Dengue virus and West Nile virus protease inhibitors
title_fullStr Dengue virus and West Nile virus protease inhibitors
title_full_unstemmed Dengue virus and West Nile virus protease inhibitors
title_sort dengue virus and west nile virus protease inhibitors
publisher Wichita State University
publishDate 2013
url http://hdl.handle.net/10057/6719
work_keys_str_mv AT aravapallisridhar denguevirusandwestnilevirusproteaseinhibitors
_version_ 1716614247438352384